Federal Judge Rules In Favor Of Sanofi, Regeneron In Patent Suit Over Cholesterol Drugs
The decision was a loss for Amgen, which had claimed that Sanofi and Regeneron’s drug Praluent infringed on its patents for the drug Repatha.
from Above the Law https://ift.tt/2zvQBsn
via Solicitors In Lagos Nigeria
from WordPress https://ift.tt/2LgImph
via Law firms in Nigeria
Comments
Post a Comment